Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014983 |
| CAS No | NA |
| Mol.F. | C12H8N2O2 |
| Mol.Wt. | 212.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014984 |
| CAS No | NA |
| Mol.F. | C18H18N2O2S |
| Mol.Wt. | 326.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014985 |
| CAS No | NA |
| Mol.F. | C18H18N2O2S |
| Mol.Wt. | 326.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014986 |
| CAS No | NA |
| Mol.F. | C18H18N2O2S |
| Mol.Wt. | 326.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014987 |
| CAS No | NA |
| Mol.F. | C18H18N2O2S |
| Mol.Wt. | 326.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014988 |
| CAS No | NA |
| Mol.F. | C17H18N2O2 |
| Mol.Wt. | 282.3 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014989 |
| CAS No | NA |
| Mol.F. | C8H10N2O2S |
| Mol.Wt. | 198.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014990 |
| CAS No | NA |
| Mol.F. | C18H18N2O2S |
| Mol.Wt. | 326.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014991 |
| CAS No | NA |
| Mol.F. | C10H9N4O3 |
| Mol.Wt. | 233.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014992 |
| CAS No | NA |
| Mol.F. | C16H20N4O3 |
| Mol.Wt. | 316.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014993 |
| CAS No | NA |
| Mol.F. | C10H12N4O3 |
| Mol.Wt. | 236.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014994 |
| CAS No | NA |
| Mol.F. | C35H44N10O7 |
| Mol.Wt. | 716.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014995 |
| CAS No | NA |
| Mol.F. | C14H20N4O2 |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014996 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014997 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014998 |
| CAS No | NA |
| Mol.F. | C15H22N4O2 |
| Mol.Wt. | 290.4 |
| INV STATUS | CUSTOM SYNTHESIS |